Manufacture and Commercialisation of Stem Cell and Gene Therapies

Course Overview

Pursue your ambitions in computing and information technology with the MSc Manufacture and Commercialisation of Stem Cell and Gene Therapies at UCL (University College London). Based in London, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time structure. Advances in stem cell and gene therapy research are changing the treatment and outcomes of many diseases and disorders, including cancer, Parkinson’s disease and osteoarthritis. With this unique industry-led MSc, you can learn the key skills, manufacturing and commercial requirements and expertise needed to translate these vital new technologies from bench to bedside. International tuition fees are £50,600 per year, home/UK fees are £19,300 per year, and a minimum IELTS score of 7.0 is required for admission. Graduates from this programme benefit from strong career prospects, with 82% student satisfaction rating, a median graduate salary of £40,000 within three years, a 95% continuation rate, and 73% of graduates in employment or further study.

What You'll Learn

Tuition Fees & Funding

UK tuition fees (2026/27) £19,300 Overseas tuition fees (2026/27) £50,600

Graduate Outcomes

Frequently Asked Questions